Timothy Wright - 01 Oct 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright
Issuer symbol
AGEN
Transactions as of
01 Oct 2025
Net transactions value
$0
Form type
4
Filing time
03 Oct 2025, 16:05:04 UTC
Previous filing
03 Jul 2025
Next filing
05 Jan 2026

Key filing fact

Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 03 Oct 2025.

Key facts

  • This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 03 Oct 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 03 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001383313 Primary reporting owner

Wright Timothy

Relationship
Director
Address
C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature
/s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright
Signature date
03 Oct 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

AGEN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares
+1,705
Change %
+8.5%
Price
Shares after
21,872
Date
01 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,705
Exercise price
Footnotes
F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2 Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3 $5.01 per Deferred Stock Unit acquired on July 1, 2025. The price of each Deferred Stock Unit acquired on October 1, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .